Company profile

Ultromics Limited

Ultromics Limited has 3 AI-enabled medical devices on the FDA list. The first decision was on December 20, 2021 and the most recent on November 15, 2024 (EchoGo Amyloidosis (1.0)). Its most common review panel is Cardiovascular (2 devices).

3AI devices
2021First decision
2024Latest decision
2Specialties

Per year

2021: 12024: 2
20212024
Ultromics Limited AI devices per year: 2021 1, 2024 2

By specialty

  • Cardiovascular2
  • Radiology1

Related guides

Top cardiovascular devices

Timeline

  1. EchoGo Amyloidosis (1.0) · Cardiovascular · SDJ
  2. EchoGo Heart Failure (2.0) · Cardiovascular · QUO
  3. EchoGo Core (2.0) · Radiology · QIH